previous arrow
next arrow

Call Us!


Enrollment Opportunities


Depression is Real

Learn about Treatment Options

More Info


Memory Appraisals at PRI

Benchmark & Sustain Your Brain!

More Info


Migraine Headache Research Study

Do you suffer with migraine headaches?

More Info

What PRI Can Do For You

A consultation at PRI gives you options, there is no cost to you and no insurance is required. Our goal is to provide a skillful personal evaluation resulting in professional recommendations; then, it’s up to you! You may decide that one of PRI’s research studies is a good opportunity for you to obtain confidential and no cost assistance. Or, you may decide to pursue other treatment options. You may or may not benefit by gaining insight into your situation and the potential for feeling better. The value of good mental health cannot be overstated!

PRI May Be a Valuable Resource to You!

Watch Our Caregiver Testimonial Video for PRI's Memory Loss Studies!

Contact The Location Nearest You

We have outpatient clinics in Los Alamitos/Long Beach, Newport Beach and Encino, making PRI easily accessible to persons living in Orange and Los Angeles Counties, including the San Fernando Valley. Contact us with any questions you may have concerning the PRI research process.
Los Alamitos/Long Beach

Pharmacology Research Institute
4281 Katella Avenue, Suite 115
Los Alamitos, CA 90720

Orange County

Pharmacology Research Institute
1601 Dove Street, Suite 290
Newport Beach, CA 92660

San Fernando Valley

Pharmacology Research Institute
6345 Balboa Blvd
Bldg III, Suite 363
Encino, California 91316

Recent News

17/Mar/2020 -

Dear Study Participants/Study Volunteers:

The safety of our clinical trial volunteers and employees is Wake Research top priority. We have been actively monitoring the Coronavirus (COVID-19) spread, and have added supplemental measures based on information from the Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO).  Our priority remains to keep our volunteers and employees safe and well-informed while doing what we can to help minimize the potential spread of the coronavirus. We will continue to dedicate significant resources and efforts to mitigate the risks while still ensuring business continuity to the greatest extent possible.

To see the steps we are taking click here.

    02/Feb/2020 -

    As the nation's leading patient organization for headache care, the National Headache Foundation (NHF) is pleased that the Institute for Clinical and Economic Review (ICER) has determined the new CGRP inhibitors to be cost effective for migraine sufferers who have not obtained satisfactory relief from other therapies. We congratulate and thank the research sponsors, scientists, and volunteers who worked diligently over the last several years to bring this new drug class to fruition. It is our hope that patients with unmet need for migraine relief will be able to access these treatments and will, at long last, find significant improvement in their lives. The NHF looks forward to continuing to elevate the voice of the patient as we address access to care and affordability issues going forward.

     - Timothy R. Smith, M.D., R.Ph., the 1st Vice President of the National Headache Foundation